Harmony Biosciences Holdings Stock Filter Stocks by Fundamentals
HRMY Stock | USD 29.35 0.05 0.17% |
Harmony Biosciences Holdings fundamentals help investors to digest information that contributes to Harmony Biosciences' financial success or failures. It also enables traders to predict the movement of Harmony Stock. The fundamental analysis module provides a way to measure Harmony Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harmony Biosciences stock.
Harmony | Cash and Equivalents |
Harmony Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Harmony Biosciences from analyzing Harmony Biosciences' financial statements. These drivers represent accounts that assess Harmony Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Harmony Biosciences' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 2.4B | 2.1B | 2.5B | 3.3B | 1.9B | 1.8B | |
Enterprise Value | 2.4B | 2.0B | 2.4B | 3.2B | 1.8B | 1.8B |
Harmony Fundamentals
Return On Equity | 0.3 | ||||
Return On Asset | 0.16 | ||||
Profit Margin | 0.22 % | ||||
Operating Margin | 0.24 % | ||||
Current Valuation | 1.51 B | ||||
Shares Outstanding | 56.77 M | ||||
Shares Owned By Insiders | 19.30 % | ||||
Shares Owned By Institutions | 90.17 % | ||||
Number Of Shares Shorted | 6.35 M | ||||
Price To Earning | 293.37 X | ||||
Price To Book | 3.59 X | ||||
Price To Sales | 2.88 X | ||||
Revenue | 582.02 M | ||||
Gross Profit | 354.37 M | ||||
EBITDA | 231.28 M | ||||
Net Income | 128.85 M | ||||
Cash And Equivalents | 254.17 M | ||||
Cash Per Share | 4.30 X | ||||
Total Debt | 193.57 M | ||||
Debt To Equity | 0.79 % | ||||
Current Ratio | 4.91 X | ||||
Book Value Per Share | 8.23 X | ||||
Cash Flow From Operations | 219.39 M | ||||
Short Ratio | 15.28 X | ||||
Earnings Per Share | 2.13 X | ||||
Target Price | 41.63 | ||||
Number Of Employees | 246 | ||||
Beta | 0.73 | ||||
Market Capitalization | 1.67 B | ||||
Total Asset | 811.45 M | ||||
Retained Earnings | (143.28 M) | ||||
Working Capital | 287.29 M | ||||
Net Asset | 811.45 M |
About Harmony Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Harmony Biosciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harmony Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harmony Biosciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Harmony Biosciences Investors Sentiment
The influence of Harmony Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Harmony. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Harmony Biosciences' public news can be used to forecast risks associated with an investment in Harmony. The trend in average sentiment can be used to explain how an investor holding Harmony can time the market purely based on public headlines and social activities around Harmony Biosciences Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Harmony Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Harmony Biosciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Harmony Biosciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Harmony Biosciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Harmony Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Harmony Biosciences' short interest history, or implied volatility extrapolated from Harmony Biosciences options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Harmony Biosciences Piotroski F Score and Harmony Biosciences Altman Z Score analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Harmony Stock analysis
When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Harmony Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harmony Biosciences. If investors know Harmony will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harmony Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 2.13 | Revenue Per Share 9.787 | Quarterly Revenue Growth 0.313 | Return On Assets 0.1616 |
The market value of Harmony Biosciences is measured differently than its book value, which is the value of Harmony that is recorded on the company's balance sheet. Investors also form their own opinion of Harmony Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Harmony Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harmony Biosciences' market value can be influenced by many factors that don't directly affect Harmony Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harmony Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Harmony Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harmony Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.